These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


415 related items for PubMed ID: 23881877

  • 1. Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.
    Parrott AC.
    Hum Psychopharmacol; 2013 Jul; 28(4):289-307. PubMed ID: 23881877
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 4. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research".
    Doblin R, Greer G, Holland J, Jerome L, Mithoefer MC, Sessa B.
    Hum Psychopharmacol; 2014 Mar; 29(2):105-8. PubMed ID: 24590541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC, Montgomery C, Wetherell MA, Downey LA, Stough C, Scholey AB.
    Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ.
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [Abstract] [Full Text] [Related]

  • 12. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
    Parrott AC.
    Neuropsychobiology; 2004 Jan; 50(4):329-35. PubMed ID: 15539865
    [Abstract] [Full Text] [Related]

  • 13. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC.
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B.
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [Abstract] [Full Text] [Related]

  • 16. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 17. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A.
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract] [Full Text] [Related]

  • 18. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC, Lasky J.
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [Abstract] [Full Text] [Related]

  • 19. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA, Rosenberg H.
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [Abstract] [Full Text] [Related]

  • 20. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC, Sands HR, Jones L, Clow A, Evans P, Downey LA, Stalder T.
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.